STOCK TITAN

DAXOR (DXR) CEO receives 30,000-share equity grant, now holds 243,694

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Feldschuh Michael Richard reported acquisition or exercise transactions in this Form 4 filing.

DAXOR CORP Chief Executive Officer Michael Richard Feldschuh reported receiving a grant of 30,000 shares of Daxor Common Stock. The award was recorded at a price of $0.00 per share and is compensation-related rather than an open-market purchase. According to a footnote, the 30,000 granted shares vest on June 23, 2026. After this grant, Feldschuh directly holds a total of 243,694 shares of Daxor Common Stock.

Positive

  • None.

Negative

  • None.
Insider Feldschuh Michael Richard
Role Chief Executive Officer
Type Security Shares Price Value
Grant/Award Daxor Common Stock 30,000 $0.00 --
Holdings After Transaction: Daxor Common Stock — 243,694 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares granted 30,000 shares Equity grant to CEO on June 23, 2026 vesting schedule
Grant price per share $0.00 per share Reported transaction price for awarded shares
Shares held after grant 243,694 shares CEO direct ownership after reported transaction
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
vest financial
"30,000 shares granted vest on June 23, 2026"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Feldschuh Michael Richard

(Last)(First)(Middle)
109 MECO LANE

(Street)
OAK RIDGE TENNESSEE 37830

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
DAXOR CORP [ DXR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Daxor Common Stock06/23/2026A30,000(1)A$0243,694D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. 30,000 shares granted vest on June 23, 2026
/s/ Michael Feldschuh06/25/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did DAXOR CORP (DXR) report on this Form 4?

DAXOR CORP reported that CEO Michael Richard Feldschuh received a grant of 30,000 shares of Daxor Common Stock. The transaction was coded as a grant, award, or other acquisition and reflects equity compensation rather than an open-market share purchase.

At what price were the 30,000 DXR shares granted to the CEO?

The 30,000 Daxor Common Stock shares were granted at a reported price of $0.00 per share. This indicates a compensation award, not a market transaction where the executive paid cash to acquire shares on the open market.

When do the 30,000 DXR shares granted to the CEO vest?

The 30,000 granted shares vest on June 23, 2026. Vesting means the executive gains full rights to the shares at that time, aligning long-term incentives with company performance through time-based ownership conditions.

How many DXR shares does the CEO hold after this grant?

After the 30,000-share grant, CEO Michael Richard Feldschuh directly holds 243,694 shares of Daxor Common Stock. This figure reflects his reported direct ownership position following the award recorded on the Form 4 filing.

Was this DXR CEO transaction a market buy or a compensation award?

This transaction was a compensation award, not a market buy. It is coded as a grant, award, or other acquisition, with 30,000 shares received at $0.00 per share, typical of stock-based executive compensation rather than open-market share purchases.